NEW YORK, June 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
http://www.reportlinker.com/p0203319/The-Future-of-Ophthalmology-Therapeutics-Analysis-and-Market-Forecasts-to-2016---Strategies-to-Counter-Generic-Erosion-in-Key-Markets.html
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
Summary
GBI Research's report, "The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 – Strategies to Counter Generic Erosion in Key Markets", provides in-depth analysis of the unmet needs, drivers and barriers that impact the global ophthalmology therapeutics market. The report analyzes the ophthalmology markets in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the ophthalmology market from 2001 to 2009, forecast forward to 2016.
- Analysis of the leading therapeutic segments, including glaucoma, macular degeneration, macular edema and allergic conjunctivitis.
- Analysis of the ophthalmology market in the leading geographies of the world, which include the US (United States), the UK (United Kingdom), Germany, France, Italy, Spain and Japan.
- Market characterization of the ophthalmology market including market size, the annual cost of therapy, sales volume and treatment usage patterns.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in the various phases of drug development.
- Competitive benchmarking of leading companies such as Pfizer, Allergan, Inc., Alcon, Inc., Novartis AG, Merck & Co Inc and Roche.
- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global ophthalmology market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.
- Develop key strategic initiatives by understanding the key focus areas of the leading companies.
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 10
2 Global Ophthalmology Therapeutics Market: Introduction 13
2.1 GBI Research Report Guidance 13
3 Global Ophthalmology Therapeutics Market: Market Overview 14
3.1 Introduction 14
3.2 Revenue Forecasts for the Global Ophthalmology Therapeutics Market 14
3.2.1 Sales Value 14
3.2.2 Annual Cost of Therapy 15
3.2.3 Treatment Usage Patterns 17
3.2.4 Generics' Share in the Global Ophthalmology Therapeutics Market 23
3.2.5 Sales of Leading Drugs 25
4 Global Ophthalmology Therapeutics Market: Therapeutic Landscape 26
4.1 Glaucoma Market 26
4.1.1 Introduction 26
4.1.2 Unmet Needs 27
4.1.3 Sales Value 28
4.1.4 Sales Volume 29
4.1.5 Annual Cost of Therapy 30
4.1.6 Treatment Usage Patterns 32
4.1.7 Geographical Segmentation 39
4.1.8 Drivers of the Glaucoma Market 41
4.1.9 Restraints for Glaucoma Market 41
4.2 Macular Edema 42
4.2.1 Introduction 42
4.2.2 Unmet Needs 42
4.2.3 Sales Value 43
4.2.4 Sales Volume 44
4.2.5 Annual Cost of Therapy 45
4.2.6 Treatment Usage Patterns 46
4.2.7 Geographical Segmentation 52
4.2.8 Drivers of the Macular Edema Market 54
4.2.9 Restraints For Macular Edema Market 54
4.3 Macular Degeneration Market 54
4.3.1 Introduction 54
4.3.2 Unmet Needs 55
4.3.3 Sales Value 55
4.3.4 Sales Volume 56
4.3.5 Annual Cost of Therapy 58
4.3.6 Treatment Usage Patterns 59
4.3.7 Geographical Segmentation 65
4.3.8 Drivers of Macular Degeneration Market 67
4.3.9 Restraints for Macular Degeneration Market 67
4.4 Allergic Conjunctivitis Market 68
4.4.1 Introduction 68
4.4.2 Unmet Needs 68
4.4.3 Sales Value 69
4.4.4 Sales Volume 70
4.4.5 Annual Cost of Therapy 71
4.4.6 Treatment Usage Patterns 72
4.4.7 Geographical Segmentation 78
4.4.8 Drivers of Allergic Conjunctivitis Market 80
4.4.9 Restraints for Allergic Conjunctivitis Market 80
5 Global Ophthalmology Therapeutics Market: Geographical Landscape 81
5.1 Geographical Break-up 81
5.2 The US 82
5.2.1 Sales Value 82
5.2.2 Annual Cost of Therapy 83
5.2.3 Treatment Usage Patterns 84
5.3 Top Five Countries in Europe 90
5.3.1 Sales Value 90
5.3.2 Annual Cost of Therapy 91
5.3.3 Treatment Usage Patterns 92
5.4 Japan 96
5.4.1 Sales Value 96
5.4.2 Annual Cost of Therapy 97
5.4.3 Treatment Usage Patterns 98
6 Global Ophthalmology Therapeutics Market: Pipeline Analysis 104
6.1 Introduction 104
6.2 Research and Development Pipeline by Phase 104
6.2.1 Research and Development Pipeline – Macular Degeneration 105
6.2.2 Research and Development Pipeline – Glaucoma 106
6.2.3 Research and Development Pipeline – Macular Edema 106
6.2.4 Research and Development Pipeline – Allergic Conjunctivitis 107
6.3 R&D Trends 107
6.3.1 New Promising Treatments for Diabetic Retinopathy 107
6.3.2 Combination Drugs Will be a Key Component of Ophthalmology Research and Development 107
6.4 Profiles of Key Drugs in the Glaucoma Pipeline 108
6.4.1 Saflutan (tafluprost) 108
6.4.2 NCX-116 (Formerly PF-03187207) 108
6.4.3 Catioprost 109
6.5 Profiles of Key Drugs in Macular Edema and Diabetic Retinopathy Pipeline 110
6.5.1 Iluvien 110
6.5.2 iCo-007 111
6.6 Profiles of Key Drugs in Macular Degeneration Pipeline 111
6.6.1 ACU-4429 111
6.6.2 AL-8309 112
6.7 Profiles of Key Drugs in Allergic Conjunctivitis Pipeline 112
6.7.1 FOV1101 (Prednisporin) 112
7 Global Ophthalmology Therapeutics Market: Competitive Landscape 113
7.1 Market Share Analysis: Ophthalmology 113
7.2 Competitive Profiling 115
7.2.1 Pfizer 115
7.2.2 Allergan, Inc. 116
7.2.3 Alcon, Inc. 118
7.2.4 Novartis AG 120
7.2.5 Merck & Co Inc 122
7.2.6 Roche 123
8 Global Ophthalmology Therapeutics Market: Strategic Consolidations 125
8.1 Overview 125
8.1.1 Valeant Pharmaceuticals International Agrees to Acquire Aton Pharma Inc 126
8.1.2 Healthcare of Today, Inc. has Acquired MacuCLEAR, Inc. 126
8.1.3 Opko Health, Inc. has Acquired Pharmacos Exakta 126
8.1.4 Sanofi-aventis Acquired Fovea Pharmaceuticals 126
8.1.5 Alcon, Inc Acquired ESBATech AG 126
8.1.6 Aton Pharma, Inc. Acquired Marketing Rights to Ophthalmology Drug 126
8.2 R&D Licensing Agreements 127
8.2.1 General 127
8.2.2 Preclinical and Discovery 127
8.2.3 Phase I 128
8.2.4 Phase II 130
8.2.5 Phase III 130
8.2.6 Approved 131
9 Global Ophthalmology Therapeutics Market: Appendix 133
9.1 Market Definitions 133
9.2 Abbreviations 133
9.3 Research Methodology 134
9.3.1 Coverage 134
9.3.2 Secondary Research 135
9.3.3 Primary Research 135
9.3.4 Forecasts 135
9.3.5 Expert Panel Validation 137
9.4 Contact Us 138
9.5 Disclaimer 138
9.6 Sources 138
1.1 List of Tables
Table 1: Ophthalmology Therapeutics Market, Global, Key Indications, 2010 14
Table 2: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2001-2009 15
Table 3: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2009-2016 15
Table 4: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2001-2009 16
Table 5: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2009-2016 17
Table 6: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009 17
Table 7: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016 18
Table 8: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2001-2009 19
Table 9: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2009-2016 19
Table 10: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2001-2009 20
Table 11: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2009-2016 20
Table 12: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2001-2009 21
Table 13: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2009-2016 22
Table 14: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2001-2009 22
Table 15: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2009-2016 23
Table 16: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2001-2009 24
Table 17: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2009-2016 24
Table 18: Ophthalmology Therapeutics Market, Global, Sales of Leading Drugs, 2009 25
Table 19: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2001-2009 29
Table 20: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2009-2016 29
Table 21: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2001-2009 30
Table 22: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2009-2016 30
Table 23: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2001-2009 31
Table 24: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2009-2016 31
Table 25: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2001-2009 33
Table 26: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2009-2016 33
Table 27: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2001-2009 34
Table 28: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2009-2016 34
Table 29: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2001-2009 35
Table 30: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2009-2016 36
Table 31: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2001-2009 37
Table 32: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2009-2016 37
Table 33: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2001-2009 38
Table 34: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2009-2016 38
Table 35: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2001-2009 40
Table 36: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2009-2016 40
Table 37: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2001-2009 44
Table 38: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2009-2016 44
Table 39: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2001-2009 45
Table 40: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2009-2016 45
Table 41: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2001-2009 46
Table 42: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2009-2016 46
Table 43: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2001-2009 47
Table 44: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2009-2016 47
Table 45: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2001-2009 48
Table 46: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2009-2016 49
Table 47: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2001-2009 50
Table 48: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2009-2016 50
Table 49: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2001-2009 51
Table 50: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2009-2016 51
Table 51: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2001-2009 53
Table 52: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2009-2016 53
Table 53: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($bn), 2001-2009 56
Table 54: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($bn), 2009-2016 56
Table 55: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2001-2009 57
Table 56: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2009-2016 57
Table 57: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2001-2009 58
Table 58: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2009-2016 58
Table 59: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2001-2009 60
Table 60: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2009-2016 60
Table 61: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Thousands), 2001-2009 61
Table 62: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Thousands), 2009-2016 61
Table 63: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Thousands), 2001-2009 62
Table 64: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Thousands), 2009-2016 62
Table 65: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Thousands), 2001-2009 63
Table 66: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Thousands), 2009-2016 64
Table 67: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Thousands), 2001-2009 65
Table 68: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Thousands), 2009-2016 65
Table 69: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2001-2009 66
Table 70: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2009-2016 66
Table 71: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2001-2009 69
Table 72: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2009-2016 70
Table 73: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2009 70
Table 74: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2016 71
Table 75: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2001-2009 71
Table 76: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2009-2016 72
Table 77: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2001-2009 73
Table 78: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2009-2016 73
Table 79: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population (Millions), 2001-2009 74
Table 80: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population (Millions), 2009-2016 74
Table 81: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2001-2009 75
Table 82: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2009-2016 75
Table 83: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2009-2009 76
Table 84: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2001-2016 77
Table 85: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2001-2009 77
Table 86: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2009-2016 78
Table 87: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market, Revenue by Geography ($m), 2001-2009 79
Table 88: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market ($m), Revenue by Geography, 2009-2016 79
Table 89: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009 82
Table 90: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016 82
Table 91: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2001-2009 83
Table 92: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2009-2016 83
Table 93: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009 84
Table 94: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016 84
Table 95: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2001-2009 85
Table 96: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2009-2016 85
Table 97: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2001-2009 86
Table 98: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2009-2016 86
Table 99: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2009 87
Table 100: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2009-2016 87
Table 101: Ophthalmology Therapeutics Market, US, Diagnosed Population (Millions), 2001-2009 88
Table 102: Ophthalmology Therapeutics Market, US, Diagnosed Population, 2001-2009 88
Table 103:Opthalmology Therapeutics Market, US, Prescription Population (Millions), 2001-2009 89
Table 104: Ophthalmology Therapeutics Market, US, Prescription Population (Millions), 2009-2016 90
Table 105:Opthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009 90
Table 106:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016 91
Table 107:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009 91
Table 108:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016 92
Table 109:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2001-2009 92
Table 110:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2009-2016 93
Table 111:Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009 96
Table 112:Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016 96
Table 113: Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009 97
Table 114:Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016 97
Table 115:Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2001-2009 98
Table 116:Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2009-2016 99
Table 117:Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2001-2009 100
Table 118:Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2009-2016 100
Table 119:Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2009 101
Table 120: Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2009-2016 101
Table 121:Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2009 102
Table 122:Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2016 102
Table 123:Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2001-2009 103
Table 124:Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2009-2016 103
Table 125:Ophthalmology Therapeutics Market, Pfizer, Pipeline Products, 2010 116
Table 126:Ophthalmology Therapeutics Market, Allergan, Pipeline Products, 2010 118
Table 127:Ophthalmology Therapeutics Market, Alcon, Pipeline Products, 2010 120
Table 128:Ophthalmology Therapeutics Market, Novartis, Pipeline Products, 2010 121
Table 129:Ophthalmology Therapeutics Market, Merck, Pipeline Products, 2010 123
Table 130:Ophthalmology Therapeutics Market, Global, Major M&A Deals, 2008-2009 125
Table 131:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical and Discovery Stage, 2008-2010 127
Table 132:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2010 129
Table 133:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2010 130
Table 134:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2010 130
Table 135:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs for Approved Products, 2008-2010 131
1.2 List of Figures
Figure 1: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2001-2016 15
Figure 2: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2001-2016 16
Figure 3: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2001-2016 17
Figure 4: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2001-2016 19
Figure 5: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2001-2016 20
Figure 6: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2001-2016 21
Figure 7: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2001-2016 22
Figure 8: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2001-2016 23
Figure 9: Ophthalmology Therapeutics Market, Global, Market Share by Indication, 2009 and 2016 26
Figure 10: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2001-2016 28
Figure 11: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2001-2016 30
Figure 12: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2001-2016 31
Figure 13: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2001-2016 32
Figure 14: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2001-2016 34
Figure 15: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2001-2016 35
Figure 16: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2001-2016 37
Figure 17: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2001-2016 38
Figure 18: Ophthalmology Therapeutics Market, Global, Glaucoma Market by Geography, 2009 and 2016 39
Figure 19: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2001-2016 40
Figure 20: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2001-2016 43
Figure 21: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2001-2016 44
Figure 22: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2001-2016 45
Figure 23: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2001-2016 47
Figure 24: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2001-2016 48
Figure 25: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Seeking Population, 2001-2016 49
Figure 26: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2001-2016 50
Figure 27: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2001-2016 51
Figure 28: Ophthalmology Therapeutics Market, Global, Macular Edema Market by Geography, 2008 and 2015 52
Figure 29: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2001-2016 53
Figure 30: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($m), 2001-2016 56
Figure 31: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2001-2016 57
Figure 32: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2001-2016 58
Figure 33: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2001-2016 59
Figure 34: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Millions), 2001-2016 61
Figure 35: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Millions), 2001-2019 62
Figure 36: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Millions), 2001-2016 63
Figure 37: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Millions), 2001-2016 64
Figure 38: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market by Geography, 2009 and 2016 65
Figure 39: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2001-2016 66
Figure 40: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2001-2016 69
Figure 41: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2016 70
Figure 42: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2001-2016 71
Figure 43: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2001-2016 72
Figure 44: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population, 2001-2016 74
Figure 45: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2001-2016 75
Figure 46: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2001-2016 76
Figure 47: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2001-2016 77
Figure 48: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market by Geography, 2009 and 2016 78
Figure 49: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market, Revenue by Geography ($m), 2001-2016 79
Figure 50: Ophthalmology Therapeutics Market, Global, Market Share by Geography, 2009 and 2016 81
Figure 51: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2016 81
Figure 52: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2001-2016 83
Figure 53: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016 84
Figure 54: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2001-2016 85
Figure 55: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2001-2016 86
Figure 56: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016 87
Figure 57: Ophthalmology Therapeutics Market, US, Diagnosed Population (Millions), 2001-2016 88
Figure 58: Ophthalmology Therapeutics Market, US, Prescription Population (Millions), 2001-2016 89
Figure 59: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2016 90
Figure 60: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016 91
Figure 61: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2001-2016 92
Figure 62: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016 93
Figure 63: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions), 2001-2016 94
Figure 64: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016 95
Figure 65: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016 95
Figure 66: Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016 96
Figure 67: Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2016 97
Figure 68: Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2001-2016 98
Figure 69: Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2001-2016 99
Figure 70: Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016 100
Figure 71: Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2016 101
Figure 72: Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016 102
Figure 73: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Indication (%), May 2010 104
Figure 74: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase (%), May 2010 105
Figure 75: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Macular Degeneration Market (%), May 2010 105
Figure 76: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Glaucoma Market (%) May 2010 106
Figure 77: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Macular Edema Market (%), May 2010 106
Figure 78: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Allergic Conjunctivitis Market (%), May 2010 107
Figure 79: Ophthalmology Therapeutics Market, Global, Market Share of Top Manufacturers (%), 2009 113
Figure 80: Ophthalmology Therapeutics Market, Global, Revenue of Top Six Players in Ophthalmology Market ($m), 2007-2010 114
Figure 81: Ophthalmology Therapeutics Market, Global, Competitive Analysis of Top Six Players in Diabetes Market, 2006-2008 115
Figure 82: Ophthalmology Therapeutics Market, Pfizer, Share of Key Ophthalmology Drugs Revenue, n = $50bn, 2009 116
Figure 83: Ophthalmology Therapeutics Market, Allergan, Share of Key Ophthalmology Drugs Revenue, n = $4.5bn, 2009 117
Figure 84: Ophthalmology Therapeutics Market, Alcon, Share of Key Ophthalmology Drugs Revenue, n = $6.5bn, 2009 119
Figure 85: Ophthalmology Therapeutics Market, Novartis, Share of Key Ophthalmology Drugs Revenue, n = $27.4bn, 2009 121
Figure 86: Ophthalmology Therapeutics Market, Merck, Share of Key Ophthalmology Drugs Revenue, n = $41.3bn, 2009 122
Figure 87: Ophthalmology Therapeutics Market, Roche, Share of Key Ophthalmology Drugs Revenue, n = $45.3bn, 2009 124
Figure 88:GBI Research Methodology, 2010 134
Figure 89:GBI Research Market Forecasting Model, 2010 137
Companies mentioned
Pfizer
Allergan, Inc.
Alcon, Inc.
Novartis AG
Merck & Co Inc
Roche
To order this report:
Generic Drug Industry: The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Advertisement
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
http://www.reportlinker.com/p0203319/The-Future-of-Ophthalmology-Therapeutics-Analysis-and-Market-Forecasts-to-2016---Strategies-to-Counter-Generic-Erosion-in-Key-Markets.html
Advertisement
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
Summary
GBI Research's report, "The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 – Strategies to Counter Generic Erosion in Key Markets", provides in-depth analysis of the unmet needs, drivers and barriers that impact the global ophthalmology therapeutics market. The report analyzes the ophthalmology markets in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the ophthalmology market from 2001 to 2009, forecast forward to 2016.
- Analysis of the leading therapeutic segments, including glaucoma, macular degeneration, macular edema and allergic conjunctivitis.
- Analysis of the ophthalmology market in the leading geographies of the world, which include the US (United States), the UK (United Kingdom), Germany, France, Italy, Spain and Japan.
- Market characterization of the ophthalmology market including market size, the annual cost of therapy, sales volume and treatment usage patterns.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in the various phases of drug development.
- Competitive benchmarking of leading companies such as Pfizer, Allergan, Inc., Alcon, Inc., Novartis AG, Merck & Co Inc and Roche.
- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global ophthalmology market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.
- Develop key strategic initiatives by understanding the key focus areas of the leading companies.
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 10
2 Global Ophthalmology Therapeutics Market: Introduction 13
2.1 GBI Research Report Guidance 13
3 Global Ophthalmology Therapeutics Market: Market Overview 14
3.1 Introduction 14
3.2 Revenue Forecasts for the Global Ophthalmology Therapeutics Market 14
3.2.1 Sales Value 14
3.2.2 Annual Cost of Therapy 15
3.2.3 Treatment Usage Patterns 17
3.2.4 Generics' Share in the Global Ophthalmology Therapeutics Market 23
3.2.5 Sales of Leading Drugs 25
4 Global Ophthalmology Therapeutics Market: Therapeutic Landscape 26
4.1 Glaucoma Market 26
4.1.1 Introduction 26
4.1.2 Unmet Needs 27
4.1.3 Sales Value 28
4.1.4 Sales Volume 29
4.1.5 Annual Cost of Therapy 30
4.1.6 Treatment Usage Patterns 32
4.1.7 Geographical Segmentation 39
4.1.8 Drivers of the Glaucoma Market 41
4.1.9 Restraints for Glaucoma Market 41
4.2 Macular Edema 42
4.2.1 Introduction 42
4.2.2 Unmet Needs 42
4.2.3 Sales Value 43
4.2.4 Sales Volume 44
4.2.5 Annual Cost of Therapy 45
4.2.6 Treatment Usage Patterns 46
4.2.7 Geographical Segmentation 52
4.2.8 Drivers of the Macular Edema Market 54
4.2.9 Restraints For Macular Edema Market 54
4.3 Macular Degeneration Market 54
4.3.1 Introduction 54
4.3.2 Unmet Needs 55
4.3.3 Sales Value 55
4.3.4 Sales Volume 56
4.3.5 Annual Cost of Therapy 58
4.3.6 Treatment Usage Patterns 59
4.3.7 Geographical Segmentation 65
4.3.8 Drivers of Macular Degeneration Market 67
4.3.9 Restraints for Macular Degeneration Market 67
4.4 Allergic Conjunctivitis Market 68
4.4.1 Introduction 68
4.4.2 Unmet Needs 68
4.4.3 Sales Value 69
4.4.4 Sales Volume 70
4.4.5 Annual Cost of Therapy 71
4.4.6 Treatment Usage Patterns 72
4.4.7 Geographical Segmentation 78
4.4.8 Drivers of Allergic Conjunctivitis Market 80
4.4.9 Restraints for Allergic Conjunctivitis Market 80
5 Global Ophthalmology Therapeutics Market: Geographical Landscape 81
5.1 Geographical Break-up 81
5.2 The US 82
5.2.1 Sales Value 82
5.2.2 Annual Cost of Therapy 83
5.2.3 Treatment Usage Patterns 84
5.3 Top Five Countries in Europe 90
5.3.1 Sales Value 90
5.3.2 Annual Cost of Therapy 91
5.3.3 Treatment Usage Patterns 92
5.4 Japan 96
5.4.1 Sales Value 96
5.4.2 Annual Cost of Therapy 97
5.4.3 Treatment Usage Patterns 98
6 Global Ophthalmology Therapeutics Market: Pipeline Analysis 104
6.1 Introduction 104
6.2 Research and Development Pipeline by Phase 104
6.2.1 Research and Development Pipeline – Macular Degeneration 105
6.2.2 Research and Development Pipeline – Glaucoma 106
6.2.3 Research and Development Pipeline – Macular Edema 106
6.2.4 Research and Development Pipeline – Allergic Conjunctivitis 107
6.3 R&D Trends 107
6.3.1 New Promising Treatments for Diabetic Retinopathy 107
6.3.2 Combination Drugs Will be a Key Component of Ophthalmology Research and Development 107
6.4 Profiles of Key Drugs in the Glaucoma Pipeline 108
6.4.1 Saflutan (tafluprost) 108
6.4.2 NCX-116 (Formerly PF-03187207) 108
6.4.3 Catioprost 109
6.5 Profiles of Key Drugs in Macular Edema and Diabetic Retinopathy Pipeline 110
6.5.1 Iluvien 110
6.5.2 iCo-007 111
6.6 Profiles of Key Drugs in Macular Degeneration Pipeline 111
6.6.1 ACU-4429 111
6.6.2 AL-8309 112
6.7 Profiles of Key Drugs in Allergic Conjunctivitis Pipeline 112
6.7.1 FOV1101 (Prednisporin) 112
7 Global Ophthalmology Therapeutics Market: Competitive Landscape 113
7.1 Market Share Analysis: Ophthalmology 113
7.2 Competitive Profiling 115
7.2.1 Pfizer 115
7.2.2 Allergan, Inc. 116
7.2.3 Alcon, Inc. 118
7.2.4 Novartis AG 120
7.2.5 Merck & Co Inc 122
7.2.6 Roche 123
8 Global Ophthalmology Therapeutics Market: Strategic Consolidations 125
8.1 Overview 125
8.1.1 Valeant Pharmaceuticals International Agrees to Acquire Aton Pharma Inc 126
8.1.2 Healthcare of Today, Inc. has Acquired MacuCLEAR, Inc. 126
8.1.3 Opko Health, Inc. has Acquired Pharmacos Exakta 126
8.1.4 Sanofi-aventis Acquired Fovea Pharmaceuticals 126
8.1.5 Alcon, Inc Acquired ESBATech AG 126
8.1.6 Aton Pharma, Inc. Acquired Marketing Rights to Ophthalmology Drug 126
8.2 R&D Licensing Agreements 127
8.2.1 General 127
8.2.2 Preclinical and Discovery 127
8.2.3 Phase I 128
8.2.4 Phase II 130
8.2.5 Phase III 130
8.2.6 Approved 131
9 Global Ophthalmology Therapeutics Market: Appendix 133
9.1 Market Definitions 133
9.2 Abbreviations 133
9.3 Research Methodology 134
9.3.1 Coverage 134
9.3.2 Secondary Research 135
9.3.3 Primary Research 135
9.3.4 Forecasts 135
9.3.5 Expert Panel Validation 137
9.4 Contact Us 138
9.5 Disclaimer 138
9.6 Sources 138
1.1 List of Tables
Table 1: Ophthalmology Therapeutics Market, Global, Key Indications, 2010 14
Table 2: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2001-2009 15
Table 3: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2009-2016 15
Table 4: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2001-2009 16
Table 5: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2009-2016 17
Table 6: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009 17
Table 7: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016 18
Table 8: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2001-2009 19
Table 9: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2009-2016 19
Table 10: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2001-2009 20
Table 11: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2009-2016 20
Table 12: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2001-2009 21
Table 13: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2009-2016 22
Table 14: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2001-2009 22
Table 15: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2009-2016 23
Table 16: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2001-2009 24
Table 17: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2009-2016 24
Table 18: Ophthalmology Therapeutics Market, Global, Sales of Leading Drugs, 2009 25
Table 19: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2001-2009 29
Table 20: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2009-2016 29
Table 21: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2001-2009 30
Table 22: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2009-2016 30
Table 23: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2001-2009 31
Table 24: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2009-2016 31
Table 25: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2001-2009 33
Table 26: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2009-2016 33
Table 27: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2001-2009 34
Table 28: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2009-2016 34
Table 29: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2001-2009 35
Table 30: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2009-2016 36
Table 31: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2001-2009 37
Table 32: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2009-2016 37
Table 33: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2001-2009 38
Table 34: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2009-2016 38
Table 35: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2001-2009 40
Table 36: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2009-2016 40
Table 37: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2001-2009 44
Table 38: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2009-2016 44
Table 39: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2001-2009 45
Table 40: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2009-2016 45
Table 41: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2001-2009 46
Table 42: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2009-2016 46
Table 43: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2001-2009 47
Table 44: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2009-2016 47
Table 45: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2001-2009 48
Table 46: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2009-2016 49
Table 47: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2001-2009 50
Table 48: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2009-2016 50
Table 49: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2001-2009 51
Table 50: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2009-2016 51
Table 51: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2001-2009 53
Table 52: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2009-2016 53
Table 53: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($bn), 2001-2009 56
Table 54: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($bn), 2009-2016 56
Table 55: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2001-2009 57
Table 56: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2009-2016 57
Table 57: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2001-2009 58
Table 58: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2009-2016 58
Table 59: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2001-2009 60
Table 60: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2009-2016 60
Table 61: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Thousands), 2001-2009 61
Table 62: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Thousands), 2009-2016 61
Table 63: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Thousands), 2001-2009 62
Table 64: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Thousands), 2009-2016 62
Table 65: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Thousands), 2001-2009 63
Table 66: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Thousands), 2009-2016 64
Table 67: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Thousands), 2001-2009 65
Table 68: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Thousands), 2009-2016 65
Table 69: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2001-2009 66
Table 70: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2009-2016 66
Table 71: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2001-2009 69
Table 72: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2009-2016 70
Table 73: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2009 70
Table 74: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2016 71
Table 75: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2001-2009 71
Table 76: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2009-2016 72
Table 77: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2001-2009 73
Table 78: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2009-2016 73
Table 79: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population (Millions), 2001-2009 74
Table 80: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population (Millions), 2009-2016 74
Table 81: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2001-2009 75
Table 82: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2009-2016 75
Table 83: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2009-2009 76
Table 84: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2001-2016 77
Table 85: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2001-2009 77
Table 86: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2009-2016 78
Table 87: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market, Revenue by Geography ($m), 2001-2009 79
Table 88: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market ($m), Revenue by Geography, 2009-2016 79
Table 89: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009 82
Table 90: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016 82
Table 91: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2001-2009 83
Table 92: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2009-2016 83
Table 93: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009 84
Table 94: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016 84
Table 95: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2001-2009 85
Table 96: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2009-2016 85
Table 97: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2001-2009 86
Table 98: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2009-2016 86
Table 99: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2009 87
Table 100: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2009-2016 87
Table 101: Ophthalmology Therapeutics Market, US, Diagnosed Population (Millions), 2001-2009 88
Table 102: Ophthalmology Therapeutics Market, US, Diagnosed Population, 2001-2009 88
Table 103:Opthalmology Therapeutics Market, US, Prescription Population (Millions), 2001-2009 89
Table 104: Ophthalmology Therapeutics Market, US, Prescription Population (Millions), 2009-2016 90
Table 105:Opthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009 90
Table 106:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016 91
Table 107:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009 91
Table 108:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016 92
Table 109:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2001-2009 92
Table 110:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2009-2016 93
Table 111:Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009 96
Table 112:Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016 96
Table 113: Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009 97
Table 114:Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016 97
Table 115:Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2001-2009 98
Table 116:Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2009-2016 99
Table 117:Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2001-2009 100
Table 118:Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2009-2016 100
Table 119:Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2009 101
Table 120: Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2009-2016 101
Table 121:Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2009 102
Table 122:Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2016 102
Table 123:Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2001-2009 103
Table 124:Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2009-2016 103
Table 125:Ophthalmology Therapeutics Market, Pfizer, Pipeline Products, 2010 116
Table 126:Ophthalmology Therapeutics Market, Allergan, Pipeline Products, 2010 118
Table 127:Ophthalmology Therapeutics Market, Alcon, Pipeline Products, 2010 120
Table 128:Ophthalmology Therapeutics Market, Novartis, Pipeline Products, 2010 121
Table 129:Ophthalmology Therapeutics Market, Merck, Pipeline Products, 2010 123
Table 130:Ophthalmology Therapeutics Market, Global, Major M&A Deals, 2008-2009 125
Table 131:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical and Discovery Stage, 2008-2010 127
Table 132:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2010 129
Table 133:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2010 130
Table 134:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2010 130
Table 135:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs for Approved Products, 2008-2010 131
1.2 List of Figures
Figure 1: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2001-2016 15
Figure 2: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2001-2016 16
Figure 3: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2001-2016 17
Figure 4: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2001-2016 19
Figure 5: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2001-2016 20
Figure 6: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2001-2016 21
Figure 7: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2001-2016 22
Figure 8: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2001-2016 23
Figure 9: Ophthalmology Therapeutics Market, Global, Market Share by Indication, 2009 and 2016 26
Figure 10: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2001-2016 28
Figure 11: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2001-2016 30
Figure 12: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2001-2016 31
Figure 13: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2001-2016 32
Figure 14: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2001-2016 34
Figure 15: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2001-2016 35
Figure 16: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2001-2016 37
Figure 17: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2001-2016 38
Figure 18: Ophthalmology Therapeutics Market, Global, Glaucoma Market by Geography, 2009 and 2016 39
Figure 19: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2001-2016 40
Figure 20: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2001-2016 43
Figure 21: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2001-2016 44
Figure 22: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2001-2016 45
Figure 23: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2001-2016 47
Figure 24: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2001-2016 48
Figure 25: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Seeking Population, 2001-2016 49
Figure 26: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2001-2016 50
Figure 27: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2001-2016 51
Figure 28: Ophthalmology Therapeutics Market, Global, Macular Edema Market by Geography, 2008 and 2015 52
Figure 29: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2001-2016 53
Figure 30: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($m), 2001-2016 56
Figure 31: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2001-2016 57
Figure 32: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2001-2016 58
Figure 33: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2001-2016 59
Figure 34: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Millions), 2001-2016 61
Figure 35: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Millions), 2001-2019 62
Figure 36: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Millions), 2001-2016 63
Figure 37: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Millions), 2001-2016 64
Figure 38: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market by Geography, 2009 and 2016 65
Figure 39: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2001-2016 66
Figure 40: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2001-2016 69
Figure 41: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2016 70
Figure 42: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2001-2016 71
Figure 43: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2001-2016 72
Figure 44: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population, 2001-2016 74
Figure 45: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2001-2016 75
Figure 46: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2001-2016 76
Figure 47: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2001-2016 77
Figure 48: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market by Geography, 2009 and 2016 78
Figure 49: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market, Revenue by Geography ($m), 2001-2016 79
Figure 50: Ophthalmology Therapeutics Market, Global, Market Share by Geography, 2009 and 2016 81
Figure 51: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2016 81
Figure 52: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2001-2016 83
Figure 53: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016 84
Figure 54: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2001-2016 85
Figure 55: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2001-2016 86
Figure 56: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016 87
Figure 57: Ophthalmology Therapeutics Market, US, Diagnosed Population (Millions), 2001-2016 88
Figure 58: Ophthalmology Therapeutics Market, US, Prescription Population (Millions), 2001-2016 89
Figure 59: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2016 90
Figure 60: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016 91
Figure 61: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2001-2016 92
Figure 62: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016 93
Figure 63: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions), 2001-2016 94
Figure 64: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016 95
Figure 65: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016 95
Figure 66: Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016 96
Figure 67: Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2016 97
Figure 68: Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2001-2016 98
Figure 69: Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2001-2016 99
Figure 70: Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016 100
Figure 71: Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2016 101
Figure 72: Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016 102
Figure 73: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Indication (%), May 2010 104
Figure 74: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase (%), May 2010 105
Figure 75: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Macular Degeneration Market (%), May 2010 105
Figure 76: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Glaucoma Market (%) May 2010 106
Figure 77: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Macular Edema Market (%), May 2010 106
Figure 78: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Allergic Conjunctivitis Market (%), May 2010 107
Figure 79: Ophthalmology Therapeutics Market, Global, Market Share of Top Manufacturers (%), 2009 113
Figure 80: Ophthalmology Therapeutics Market, Global, Revenue of Top Six Players in Ophthalmology Market ($m), 2007-2010 114
Figure 81: Ophthalmology Therapeutics Market, Global, Competitive Analysis of Top Six Players in Diabetes Market, 2006-2008 115
Figure 82: Ophthalmology Therapeutics Market, Pfizer, Share of Key Ophthalmology Drugs Revenue, n = $50bn, 2009 116
Figure 83: Ophthalmology Therapeutics Market, Allergan, Share of Key Ophthalmology Drugs Revenue, n = $4.5bn, 2009 117
Figure 84: Ophthalmology Therapeutics Market, Alcon, Share of Key Ophthalmology Drugs Revenue, n = $6.5bn, 2009 119
Figure 85: Ophthalmology Therapeutics Market, Novartis, Share of Key Ophthalmology Drugs Revenue, n = $27.4bn, 2009 121
Figure 86: Ophthalmology Therapeutics Market, Merck, Share of Key Ophthalmology Drugs Revenue, n = $41.3bn, 2009 122
Figure 87: Ophthalmology Therapeutics Market, Roche, Share of Key Ophthalmology Drugs Revenue, n = $45.3bn, 2009 124
Figure 88:GBI Research Methodology, 2010 134
Figure 89:GBI Research Market Forecasting Model, 2010 137
Companies mentioned
Pfizer
Allergan, Inc.
Alcon, Inc.
Novartis AG
Merck & Co Inc
Roche
To order this report:
Generic Drug Industry: The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
